Evolus share price logo

Evolus

NASDAQ: EOLS

Small Cap

$7.14

-0.55

(-7.15%)

as on

Evolus Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.93
    $7.68
    downward going graph

    2.94%

    Downside

    7.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.86
    $9.31
    downward going graph

    45.94%

    Downside

    30.39%

    Upside

    downward going graph

Evolus share price movements today

Previous Close
$7.69
Open
$7.68
Volume
2.4M
Market Cap
$507.9M
Day's Low - High
$6.93 - $7.68
52 Week Low - High
$3.86 - $9.31

Evolus Historical Returns

1 Month Return
-21.1 %
3 Month Return
+ 3.48 %
1 Year Return
+ 9.85 %
3 Year Return
-18.12 %
5 Year Return
-7.63 %

Evolus Stock Fundamentals & Key Indicators

Check Evolus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$507.9M

EPS (TTM)

-0.518

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.07

Industry PE ratio

3.00

PEG Ratio

-0.21

EBITDA

-10.2M

Revenue (TTM)

316.5M

Profit Margin

66.25%

Return On Equity TTM

123.11%

Evolus vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$507.9M-7.63%-15.0766.25%0.00%
Buy$24.5B191.39%19.0486.14%0.00%
Buy$20.4B29.41%-48.8134.83%2.75%
Buy$39.2BNA18.0765.57%2.27%
Buy$28.9B-64.48%11.4170.87%3.02%

Stock Returns calculator for Evolus Stock including INR - Dollar returns

The Evolus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Evolus investment value today

Current value as on today

₹1,19,230

Returns

₹19,230

(+19.23%)

Returns from Evolus Stock

₹9,846 (+9.85%)

Dollar Impact

₹9,384 (+9.38%)

Analyst Recommendation on Evolus Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Evolus. Average target price of $15

Evolus Share Price Target

Get share price movements and forecasts by analysts on Evolus.

What analysts predicted

52.4%UPSIDE

Target Price

$15

Current Price

$7.14

Analyzed by

4 Analysts

High

$17

Target

$15.00

Low

$13

Evolus target price $15, a slight upside of 52.4% compared to current price of $7.14. According to 4 analysts rating.

Indian Investors' Interest in Evolus Stock

Search interest for Evolus Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-46% versus previous 30 day period

Evolus Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
59
66
61
78
68
69
68
90
73
84
Gross Profit
40
47
42
50
46
45
45
59
47
57
Operating Income
-8
-7
-15
-2
-15
-10
-11
0
-6
-4
EBITDA
-6
-5
-13
0
-12
-7
-9
7
-3
-4
Interest Expense
4
4
4
4
4
7
4
3
3
4
Depreciation
1
1
1
1
1
2
1
2
2
-
Income Before Tax
-13
-11
-19
-6
-18
-17
-15
0
-10
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-13
-11
-19
-6
-18
-17
-15
0
-10
-8
Net Profit Margin
68.26%
70.35%
70.17%
63.77%
68.09%
65.31%
66.47%
65.66%
64.75%
68.00%

Evolus Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
34
56
99
148
202
266
297
Gross Profit
0
0
26
38
56
89
140
182
192
Operating Income
-11
-46
-98
-153
-44
-65
-49
-34
-37
EBITDA
-11
-46
-92
-144
-39
-53
-41
-25
-22
Interest Expense
-
0
7
10
1
9
13
18
19
Depreciation
0
0
5
7
6
3
5
6
8
Income Before Tax
-11
-46
-105
-162
-46
-74
-61
-49
-50
Income Tax Expense
-7
0
-15
0
0
0
0
0
0
Net Income
-4
-46
-90
-163
-46
-74
-61
-50
-51
Net Profit Margin
0.00%
0.00%
77.05%
67.64%
56.32%
60.41%
69.54%
68.46%
64.86%

Evolus Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-11
-19
-6
-18
-17
-15
0
-10
-8
Operating Cash Flow
-10
-6
-5
4
-15
-24
-14
12
-9
-3
Investing Cash Flow
0
-1
-1
-1
-1
-2
-2
-2
-1
0
Financing Cash Flow
45
4
-1
-1
-1
20
-1
0
7
0
Change in Cash
34
-3
-8
1
-19
-6
-18
10
-4
-4

Evolus Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-46
-90
-163
-46
-74
-61
-50
-51
Operating Cash Flow
-13
-25
-93
-57
-33
-84
-34
-17
-42
Investing Cash Flow
-
0
-23
12
4
-2
-1
-4
-8
Financing Cash Flow
13
118
133
38
73
-4
44
47
17
Change in Cash
-
93
16
-7
43
-92
8
24
-33

Global Institutional Holdings in Evolus

Check out the Institutions with significant holdings in Evolus.

Funds
Holdings
Vanguard
4.46%
iShares
4.10%
Joseph Edelman
3.72%
VANGUARD INDEX FUNDS
3.65%
Xtrackers
1.88%

Insights on Evolus

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 73.13M → 84.08M (in $), with an average increase of 13.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -10.67M → -8.05M (in $), with an average increase of 32.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 72.7% return, outperforming this stock by 62.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 81.4% return, outperforming this stock by 96.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EOLS stock has moved down by -10.4%

About Evolus

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
OrganisationEvolus
Headquarters520 Newport Center Drive, Newport Beach, CA, 92660, US
IndustryDrug Manufacturers - Specialty & Generic
CEODavid Moatazedi

Key Management of Evolus

Name

Title

Ms. Jessica Novak

Senior Vice President of Human Resources

Mr. Jeffrey J. Plumer

Corporate Secretary

Mr. David Moatazedi

President, CEO & Director

Ms. Tatjana Mitchell

Chief Financial Officer

Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.

Chief Medical Officer and Head of Research & Development

Mr. Nareg Sagherian

Head of Global Investor Relations & Corporate Communications

Mr. Kurt Knab

Senior Vice President of Sales

FAQs

What is Evolus share price today?

Evolus share price today is $7.14 as on at the close of the market. Evolus share today touched a day high of $7.68 and a low of $6.93.

What is the 52 week high and 52 week low for Evolus share?

Evolus share touched a 52 week high of $9.31 on and a 52 week low of $3.86 on . Evolus stock price today i.e. is closed at $7.14,which is 23.31% down from its 52 week high and 84.97% up from its 52 week low.

What is Evolus's market capitalisation today?

Evolus market capitalisation is $0.00T as on .

How to invest in Evolus Stock (EOLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evolus on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Evolus Stock (EOLS) from India?

Indian investors can start investing in Evolus (EOLS) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Evolus stock (as per the Rupee-Dollar exchange rate as on ). Based on Evolus share’s latest price of $7.14 as on October 3, 2026 at 8:46 am IST, you will get 1.4006 shares of Evolus. Learn more about fractional shares .

What are the returns that Evolus has given to Indian investors in the last 5 years?

Evolus stock has given -7.63% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?